Saint Louis, Missouri — According to state and local economic development sources Octapharma Plasma plans to invest $900,000.00 to build new space in Saint Louis. The company plans to occupy the new space at 3843 Gravois Ave in Saint Louis, on or about November 1, 2020. According to the company website Octapharma Plasma, Inc. is a U.S.-based company that collects plasma used to create life-saving medicines for patients around the world. We run more than 80 donation centers in the U.S and employ more than 3,500 people nationally. Our donors are our most valued customers because they make saving and improving lives possible every day. Octapharma Plasma is part of Octapharma AG, one of the world’s largest makers of plasma products. Based in Lachen, Switzerland, our parent company has been committed to patient care and medical innovation since 1983. We have biopharmaceutical experience in 113 countries and employ more than 7,000 people globally. We dedicate our life’s work to improving the health and lives of people worldwide by providing quality plasma products.

To learn more about Octapharma Plasma, visit http://octapharmaplasma.com/

Company Contact:
Judy Smith, Chief Operating Officer
judy.smith@octapharmaplasma.com
704-654-4600

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved